The Roadmap to Successful Xpert Implementation - 37 steps -

Slides:



Advertisements
Similar presentations
Project Cycle Management
Advertisements

Quality assurance Kari Kuulasmaa 1 st EHES Training Seminar, February 2010, Rome.
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
Planning M&E to Tell Our ACSM Story. Objectives Discuss how ACSM activities can address barriers to help reach national TB control targets. Describe how.
New Technologies for Tuberculosis Control: Programme Perspective Draft Definitions Retooling Task Force Meeting Geneva, Switzerland January 2008.
Framework and Toolkit for UN Coherence, Effectiveness and Relevance at Country Level: Step 2 – Prioritize and set outcomes.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Towards a model M&E system for AIDS programs Kampala April
Achieve Benefit from IT Projects. Aim This presentation is prepared to support and give a general overview of the ‘How to Achieve Benefits from IT Projects’
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Technical and Operational Considerations for Scaling Up
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
TB Seminar 2014 Agenda and issues in NTP M&E System ARUN GAUTAM, CHIEF, PME SECTION, NTC.
Comprehensive M&E Systems
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Instrument and Test Forecasting: Considerations in Implementation of New Diagnostics Jason Williams Principal Laboratory Advisor.
1 Module PLANNING AND ORGANIZING EXTERNAL QUALITY ASSESSMENT.
1 HIV Drug Resistance Training Module 9: A Systems Approach to Laboratory Quality.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Process of formulation of Strategic Plans Define the organisation's mission Set Goals and Objectives Conduct SWOT Analyse existing strategies Develop new.
Laboratory Capacity Building in Africa Tsehaynesh Messele, PhD CEO, ASLM.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Monitoring and Evaluation Module 12 – March 2010.
Unit 10. Monitoring and evaluation
Patient Safety Friendly Hospital Intiative Purpose Implementation of a set of patient safety standards in hospitals Implementation of a set of patient.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
Partnering initiatives to stop TB at country level Inclusive platform for all partners interested and working for TB prevention, care, control Different.
Circuit Rider Training Program (CRTP) Circuit Rider Professional Association Annual General Meeting and Conference August 30, 2012.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
Country Team Action Plan Cambodia. Tracks 1 & 2 2 Where are we now? Key program/country needs and challenges –MMR of 472 / 100,000 hasn’t budged in 15.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Monitoring and Evaluation in MCH Programs and Projects MCH in Developing Countries Feb 24, 2009.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Strengthening SME system for national programmes moving from transmission reduction to elimination phase Cambodia.
Strengthening National Lab. Network for diagnosis of TB and HIV: Challenges and solutions. Nicholas Wambua MD; MPH; DTCE. Technical Advisor -Tuberculosis.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Monitoring and Evaluation in MCH Programs and Projects MCH in Developing Countries Feb 9, 2012.
Demonstrating and Promoting Best Techniques and Practices for Reducing Health Care Waste to Avoid Environmental Releases of Dioxins and Mercury Project.
Jeroen Van’t Pad Bosch, Technical Director Elizabeth Glaser Pediatric AIDS Foundation, Tanzania EGPAF PROJECT HEART STRENGTHENING HEALTH SYSTEMS THROUGH.
Assessing Logistics System Supply Chain Management 1.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
1 Strengthening PMTCT Data Reporting and Use through Supportive Supervision and Routine Performance Evaluation: Experiences from Dedza and Ntcheu Districts,
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
EDM Strategy for Working with Countries: the Uganda Example
Patricia Fassinou Ekouévi
Monitoring and Evaluation: A Review of Terms
Integrated Testing on the GeneXpert
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
11 ii. Develop a plan for aDSM
Integrated Testing on the GeneXpert
12. Role of national and international technical and funding partners in the implementation of aDSM Multi-partner training package on active TB drug safety.
11 i. Create a national coordinating mechanism for aDSM
INTRODUCTION OF URINE LF-LAM TEST IN SA
Find and Treat All Missing Persons with TB
Sustainable Transition / Handover of malaria TB and HIV Global Fund Grants Generic 2018.
Introducing new drugs and shorter regimen
SRH & HIV Linkages Agenda
Mentoring in OCB HIV/TB Projects
Ministry of Health, Kenya
Comprehensive M&E Systems
Multi-disease diagnostic integration
Overview of the POC EID Training Toolkit
Presentation transcript:

The Roadmap to Successful Xpert Implementation - 37 steps -

Phases of Xpert implementation NTP establishes National Xpert Working Group Working Group develops draft Xpert strategy Site assessments Finalize Xpert Strategy Preparation Training & Installation Monitoring & Evaluation Scale-up Strategy

Critical pathway to Xpert implementation

Phase 1: NTP establishes National Xpert Working Group Talk with the NTP/ MoH Mapping of NTP/ partner activities Set-up Xpert WG Meeting of the Xpert WG Convene stakeholders meeting

ActivitiesExpected outcomes -Talk with the NTP/MoH -Mapping of NTP/partner activities -Convene stakeholders meeting -Set-up an Xpert working group (important to have representation of program managers and clinicians (TB, pediatricians, HIV) -Arrange for an Xpert WG meeting -Planning & coordination body established - Commitment to start using Xpert,based on understanding of program and cost implications Phase 1: NTP establishes National Xpert Working Group

Agree on eligible suspect groups Draft diagnostic algorithm Provide background information on Xpert Determine objectives of Xpert Review epidemiology situation Perform SWOT Analysis of diagnostic/ treatment situation Develop M&E framework Preselect potential sites Phase 2: Working Group develops draft Xpert strategy

Phase 1: Introduction ActivitiesExpected outcomes -Provide background information on Xpert -Evaluate epidemiologic situation -Perform SWOT analysis of diagnostic and treatment situation -Determine objectives for Xpert -Agree on eligible suspects -Develop a draft algorithm (describing the complete new diagnositic and treatment pathways) -Pre-select potential sites for Xpert placement -Draft an M&E framework -A draft national Xpert strategy, national algorithms and SOPs have been developed - Commitment of all partners and professional groups to use the national algorithms Phase 2: Working Group develops draft Xpert strategy

Phase 2: Strategic Planning Collect estimated number of suspects per site Assess treatment capacity Phase 3: Site Assessments Asses HR requirements Assess requirements for laboratory renovation Phase 3: Site Assessments

Phase 1: Introduction ActivitiesExpected outcomes -Collect data on estimated number of suspects from sites -Idenfity effectiveness of patient/sample referral network -Identify training needs at sites -Identify requirements for laboratory renovation & staffing -Assess treatment quality and capacity -Essential information for finalizing the national strategy, algorithms and development of an activity plan have been collected Phase 3: Site Assessments

Finalize M&E Plan - Select final sites for Xpert placement Finalize diagnostic algorithms & suspect selection - Develop annual activity plan Develop budget Phase 4: Finalize Xpert strategy

Phase 1: Introduction ActivitiesExpected outcomes -Select final sites for Xpert placement & prioritization for phased implementation -Finalize diagnostic & suspect selection -Develop M&E plan -Develop an annual activity plan -Forecast Xpert supplies and drug needs -Develop a budget -National Xpert strategy has been finalized, including an annual activity plan and budget Phase 4: Finalize Xpert strategy

Establish waste management system Establish Xpert maintenance system Establish cartridge supply system Revise registers & request forms Develop clinical protocols Develop SOPs Conduct lab renovations Establish supervision system Finalize procurement Phase 5: Preparation

Phase 1: Introduction ActivitiesExpected outcomes -Conduct laboratory renovations -Develop clinical protocols -Revise registers & request forms -Develop site reporting template (M&E) -Develop SOPs -Develop training plan -Develop a supervision plan -Finalize procurement -Set-up a cartridge supply system -Develop a maintenance plan -Develop waste-management plan Lab renovations completed, documents and lab support systems (maintenance, supervision etc) developed Phase 5: Preparation

Conduct Training of trainers Conduct site specific training Install GeneXpert instruments Phase 6: Training & Installation

Phase 1: Introduction ActivitiesExpected outcomes -Conduct training of trainers (ToT) -Conduct site-specific trainings of laboratory & clinical staff -Install the GeneXpert instruments -Place revised registers and SOPs in laboratory and clinics -Routine use of Xpert has started Phase 6: Training & Installation

Conduct monitoring & supervision visits Evaluate the quality & impact of Xpert use Phase 7: Monitoring & Evaluation

ActivitiesExpected outcomes -Conduct monitoring & supervision visits -Improve lab operator skills (mentorship) -Improve recording & reporting -Collect monthly (lab) quality indicators -Evalute the quality and impact of Xpert use -Quality of Xpert routine use is ensured -Benefits and obstacles of Xpert used are evaluated Phase 7: Monitoring & Evaluation

Determine perspectives for the future role of Xpert in the country: Final national guideline Phase 8: Scale up Strategy

Phase 1: Introduction ActivitiesExpected outcomes -Determine perspectives for the future role of Xpert in the country -Develop final national guideline -Finalized national Xpert scale up strategy Phase 8: Scale up Strategy